BioCentury
ARTICLE | Company News

Memory, Roche Alzheimer's deal

July 30, 2002 7:00 AM UTC

Roche (SWX:ROCZ) received a worldwide exclusive license to preclinical Alzheimer's compounds from Memory (Montvale, N.J.). The companies also will develop compounds within the same class for other ind...